PHASE-3 DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF POMALIDOMIDE IN PERSONS WITH MYELOPROLIFERATIVE-NEOPLASM-ASSOCIATED MYELOFIBROSIS AND RBC-TRANSFUSION-DEPENDENCE MYELOFIBROSIS AND RBC-TRANSFUSION-DEPENDENCE: